VentiRx Pharmaceuticals
Seattle, US
Founders & leadership
KF
Kathleen FanningNamed on SEC filing
SG
Steven Gillis, Ph.D.Named on SEC filing
AS
Atul SaranNamed on SEC filing
PH
Patrick HeronNamed on SEC filing
RM
Robert M. Hershberg, M.D., Ph.D.Named on SEC filing
RL
Ron LauferNamed on SEC filing
NV
Nicole VitulloNamed on SEC filing
KS
Kent SnyderNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$65.6M disclosed across 2 rounds · 2010–2014
▶$15MraisedSep 2014 · 1 investors · BiotechnologyRule 506(b)
▶$15MraisedSep 2014 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Ron LauferDirector
- Atul SaranDirector
- Kathleen FanningExecutive Officer
- Robert M. Hershberg, M.D., Ph.D.Executive Officer, Director
- Kent SnyderDirector
- Steven Gillis, Ph.D.Director
- Patrick HeronDirector
- Nicole VitulloDirector
- Offering amount
- $15M
- Amount sold
- $15M
- First sale
- Sep 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$50.6MraisedSep 2014 · 9 investors · BiotechnologyRule 506(b)
▶$50.6MraisedSep 2014 · 9 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Kathleen FanningExecutive Officer
- Steven Gillis, Ph.D.Director
- Atul SaranDirector
- Patrick HeronDirector
- Robert M. Hershberg, M.D., Ph.D.Executive Officer, Director
- Ron LauferDirector
- Nicole VitulloDirector
- Kent SnyderDirector
- Offering amount
- $53.1M
- Amount sold
- $50.6M
- First sale
- Jan 2010
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has VentiRx Pharmaceuticals raised?
- VentiRx Pharmaceuticals has disclosed $65.6M raised across 2 rounds.
- Where is VentiRx Pharmaceuticals headquartered?
- VentiRx Pharmaceuticals is headquartered in Seattle, US.